Psilocybin & End-of-Life
Explore mushroom research and guides on psilocybin & end-of-life.
How Psilocybin Changes the Relationship with Mortality
About 90% report less fear of death after psilocybin, paralleling near-death experiences. What the evidence shows about ego dissolution and mortality.
Psilocybin and Demoralization: Hope for the Hopeless
In hospice patients still declining, psilocybin cut demoralization by 8.8 points. What the PATH trial and NYU long-term data reveal about psilocybin and cancer.
Psilocybin for Cancer Anxiety: The NYU and Hopkins Trials
In December 2016, two coordinated RCTs published back-to-back: Hopkins found 78% depression response at 6 months, NYU 60-80% at 6.5 months. Here's what the trials actually showed — and where the evidence is thinner than headlines suggest.
Psilocybin in Palliative Care: Research and Ethics
What does research say about psilocybin in palliative care? Evidence shows 57-79% symptom reduction, but access barriers and unresolved ethics remain.